First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA+ breast cancer patients 06/04/2018 Health Problems
Multigene testing replacing BRCA tests for breast cancer risk, researcher says 05/11/2018 Health Problems
